InvestorsHub Logo
Followers 29
Posts 451
Boards Moderated 0
Alias Born 10/04/2008

Re: aikifredicist post# 132391

Friday, 07/12/2013 7:12:15 PM

Friday, July 12, 2013 7:12:15 PM

Post# of 345743
Aikifred-- You make fair points.

In reply, it would just point out PPHM's entire communications MO is overwhelmingly cautious and conservative. I don't think they would re-brand the Company and announce both preclinical immunotherapy combo studies AND a clinical immunotherapy combo study to start before year-end unless the "well advanced" preclinical work had already yielded some very encouraging data.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News